The role of these hormones in obesity pathogenesis is not yet delineated but peripheral infusion of ghrelin is shown to promote food intake in humans [33] and decrease fat oxidation and promote adiposity in animal models [32], whereas infusion of PYY and GLP dampens appetite and food intake in humans [34–36]. This evidence concerns the gene GHRL and obesity due to melanocortin 4 receptor deficiency.